Literature DB >> 9821446

Prevalence of child and adolescent psychiatric disorders: the Zürich Epidemiological Study.

H C Steinhausen1, C W Metzke, M Meier, R Kannenberg.   

Abstract

Psychiatric disorders were studied in an epidemiological and representative sample of 1964 pupils attending the first to ninth grade in various types of schools in the Canton of Zürich, Switzerland. Using a two-stage procedure, parents were asked to respond to a standardized behaviour problem checklist in the screening phase. In the second stage, structured interviews were performed with 399 parents representing both screen positive and control children. DSM-III-R diagnoses were derived from the interviews. The total prevalence figure for any disorder amounted to 22.5%. Prevalence rates were influenced by the multi-screen procedure. Among various correlates, sex, nationality, age and residence were to some extent significant. Comorbid disorders were present in 12.5% of the subjects.

Entities:  

Mesh:

Year:  1998        PMID: 9821446     DOI: 10.1111/j.1600-0447.1998.tb10082.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  31 in total

Review 1.  Does the prevalence of CD and ODD vary across cultures?

Authors:  Glorisa Canino; Guilherme Polanczyk; Jose J Bauermeister; Luis A Rohde; Paul J Frick
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-06-09       Impact factor: 4.328

2.  Psychiatric disorders in 8-9-year-old children based on a diagnostic interview with the parents.

Authors:  F Almqvist; K Puura; K Kumpulainen; E Tuompo-Johansson; I Henttonen; E Huikko; S Linna; K Ikäheimo; E Aronen; S Katainen; J Piha; I Moilanen; E Räsänen; T Tamminen
Journal:  Eur Child Adolesc Psychiatry       Date:  1999       Impact factor: 4.785

3.  The use of the development and well-being assessment (DAWBA) in clinical practice: a randomized trial.

Authors:  Marcel Aebi; Christine Kuhn; Christa Winkler Metzke; Argyris Stringaris; Robert Goodman; Hans-Christoph Steinhausen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-22       Impact factor: 4.785

4.  A recruitment method to obtain community samples of children for survey research in Switzerland.

Authors:  Meichun Mohler-Kuo; Ben Jann; Michelle Dey; Ueli Zellweger
Journal:  Int J Public Health       Date:  2011-04-19       Impact factor: 3.380

5.  Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder.

Authors:  D Purper-Ouakil; S Cortese; M Wohl; M Asch; E Acquaviva; B Falissard; G Michel; P Gorwood; M C Mouren
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

6.  Psychosocial adaptation of adolescent migrants in a Swiss community survey.

Authors:  Hans-Christoph Steinhausen; Cinzia Bearth-Carrari; Christa Winkler Metzke
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-09-25       Impact factor: 4.328

7.  Cross-sectional evaluation of cognitive functioning in children, adolescents and young adults with ADHD.

Authors:  Ivo Marx; Thomas Hübner; Sabine C Herpertz; Christoph Berger; Erik Reuter; Tilo Kircher; Beate Herpertz-Dahlmann; Kerstin Konrad
Journal:  J Neural Transm (Vienna)       Date:  2009-12-02       Impact factor: 3.575

8.  ADORE -- Attention-Deficit Hyperactivity Disorder Observational Research in Europe.

Authors:  Stephen J Ralston; Maria J M Lorenzo
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

9.  Socioeconomic inequalities in general and psychological health among adolescents: a cross-sectional study in senior high schools in Greece.

Authors:  Konstantina Magklara; Petros Skapinakis; Dimitrios Niakas; Stefanos Bellos; Anastasia Zissi; Stylianos Stylianidis; Venetsanos Mavreas
Journal:  Int J Equity Health       Date:  2010-01-23

10.  Incidence of childhood psychiatric disorders in India.

Authors:  Savita Malhotra; Adarsh Kohli; Mehak Kapoor; Basant Pradhan
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.